3SBio Inc. joined the parade of China biopharmas reporting sharply higher revenues. In the first quarter of 2008, 3SBio saw its sales jump 57% to 55.5 million RMB ($7.9 million). Gross profit climbed 56% to 50.6 million RMB ($7.2 million). However, net income did not keep pace, rising a much smaller 22% to 14.2 million RMB ($2 million). More details...

Stock Symbol: (NSDQ: SSRX)